U.S. RESEARCH ROUNDUP- Ally Financial, GE Vernova, Navient

Reuters04-03

April 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ally Financial, GE Vernova and Navient on Wednesday.

HIGHLIGHTS

* Ally Financial Inc : JP Morgan cuts to underweight from neutral

* GE Vernova Inc : RBC initiates coverage With Outperform rating; target

price $160

* Navient Corp : JP Morgan raises to neutral from underweight

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Alignment Healthcare Inc : Stephens cuts target price to $6 from $8.50

* Ally Financial Inc : JP Morgan cuts to underweight from neutral

* Ally Financial Inc : JP Morgan raises target price to $39 from $37

* American Express Co : JP Morgan raises target price to $240 from $214

* Applied Industrial Technologies : Oppenheimer initiates coverage with

outperform rating

* Applied Industrial Technologies : Oppenheimer initiates coverage with PT $235

* Beam Therapeutics Inc : Leerink Partners cuts target price to $27 from $28

* $Capital One Financial Corp(COF-N)$ : JP Morgan raises target price to $152 from $134

* Centene Corp : Stephens cuts target price to $83 from $85

* Discover Financial Services : JP Morgan raises target price to $120 from $110

* Dover Corp : JP Morgan raises target price to $180 from $178

* Elevance Health Inc : Stephens cuts target price to $580 from $585

* Enact Holdings Inc : JP Morgan raises target price to $31 from $30

* Endeavor Group Holdings Inc : TD Cowen cuts target price to $27.5 from $30

* GE Vernova Inc : RBC initiates coverage With Outperform rating; target price

$160

* Genelux Corp : Maxim Group cuts target price to $18 from $40

* Gritstone Bio Inc : BTIG cuts target price to $3 from $20

* Guild Holdings Co : JP Morgan cuts to underweight from neutral

* HanesBrands Inc : Wedbush raises target price to $5 from $4.50

* Hartford Financial Services Group Inc : TD Cowen raises PT to $144 from $135

* Hilton Worldwide Holdings : HSBC raises target price to $254 from $219

* Humana Inc : Stephens cuts target price to $395 from $430

* Lifecore Biomedical Inc : Stephens cuts target price to $6 from $8

* Navient Corp : JP Morgan cuts target price to $17 from $18

* Navient Corp : JP Morgan raises to neutral from underweight

* NMI Holdings Inc : JP Morgan raises target price to $35 from $34

* Omega Therapeutics Inc : Piper Sandler cuts target price to $9 from $10

* Omnicom Group Inc : Macquarie raises target price to $110 from $100

* Onemain Holdings Inc : JP Morgan raises target price to $51 from $47

* Parker-Hannifin Corp : Stifel raises target price to $629 from $588

* Paychex Inc : JP Morgan cuts target price to $120 from $126

* Paychex Inc : TD Cowen cuts target price to $121 from $122

* Prime Medicine Inc : Wedbush initiates coverage with outperform rating

* Prime Medicine Inc : Wedbush initiates coverage with target price $12

* PVH Corp : Wedbush raises target price to $113 from $108

* Sallie Mae : JP Morgan raises target price to $22 from $20

* SLB : RBC raises target price to $69 from $66

* Stoke Therapeutics Inc : JP Morgan raises target price to $14 from $13

* Sutro Biopharma Inc : Piper Sandler cuts target price to $11 from $12

* Sutro Biopharma Inc : Truist Securities cuts target price to $18 from $25

* Synchrony Financial : JP Morgan raises target price to $42 from $39

* Tesla Inc : TD Cowen cuts target price to $160 from $180

* UnitedHealth Group Inc : Stephens cuts target price to $545 from $570

* Valero Energy Corp : Piper Sandler raises target price to $198 from $161

* Walgreens : TD Cowen cuts target price to $35 from $37

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment